These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3298420)

  • 1. A clinical study of the selective MAO-A-inhibitor moclobemide (Ro 11-1163): a comparison of 2 different dosages with particular reference to platelet MAO-activity and urinary MHPG-excretion.
    Lensch K; Fuchs G; Böning J; Milech U
    Int Clin Psychopharmacol; 1987 Apr; 2(2):165-71. PubMed ID: 3298420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor.
    Casacchia M; Carolei A; Barba C; Frontoni M; Rossi A; Meco G; Zylberman MR
    Pharmacopsychiatry; 1984 Jul; 17(4):122-5. PubMed ID: 6382361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DST urinary MHPG.SO4 excretion and platelet MAO activity in depression].
    Zhou DF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):274-8. PubMed ID: 3833511
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical, endocrine and neurochemical effects of moclobemide in depressed patients.
    Alevizos B; Hatzimanolis J; Markianos M; Stefanis CN
    Acta Psychiatr Scand; 1993 Apr; 87(4):285-90. PubMed ID: 8488751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
    Sharma RP; Janicak PG; Javaid JI; Pandey GN; Gierl B; Davis JM
    Am J Psychiatry; 1990 Oct; 147(10):1318-21. PubMed ID: 2169208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of moclobemide on clinical and neurochemical variables in depressed patients (preliminary findings).
    Stefanis CN; Alevizos B; Markianos M; Hatzimanolis J
    J Neural Transm Suppl; 1988; 26():87-95. PubMed ID: 2452231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical effects of L-deprenyl in atypical depressives.
    Liebowitz MR; Karoum F; Quitkin FM; Davies SO; Schwartz D; Levitt M; Linnoila M
    Biol Psychiatry; 1985 May; 20(5):558-65. PubMed ID: 3921065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenelzine in depressed patients. Effects on urinary MHPG excretion in relation to clinical response.
    Beckmann H; Murphy DL
    Neuropsychobiology; 1977; 3(1):49-55. PubMed ID: 895998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant effect of Ro 11-1163, a new MAO inhibitor.
    Stefanis CN; Alevizos BH; Papadimitriou GN
    Int Pharmacopsychiatry; 1982; 17(1):43-8. PubMed ID: 7045018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites.
    Wiesel FA; Raaflaub J; Kettler R
    Eur J Clin Pharmacol; 1985; 28(1):89-95. PubMed ID: 3987791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R
    Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
    Koulu M; Scheinin M; Kaarttinen A; Kallio J; Pyykkö K; Vuorinen J; Zimmer RH
    Br J Clin Pharmacol; 1989 Feb; 27(2):243-55. PubMed ID: 2469451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High urinary norepinephrine excretion in major depressive disorders: effects of a new type of MAO inhibitor (Moclobemide, RO 11-1163).
    Dajas F; Lista A; Barbeito L
    Acta Psychiatr Scand; 1984 Nov; 70(5):432-7. PubMed ID: 6516893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
    Nair NP; Ahmed SK; Kin NM
    J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of monoamine oxidase A inhibition on plasma biogenic amine metabolites in depressed patients.
    Markianos M; Alevizos B; Hatzimanolis J; Stefanis C
    Psychiatry Res; 1994 Jun; 52(3):259-64. PubMed ID: 7527564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, biochemical and psychometric findings with the new MAO-A-inhibitors moclobemide and brofaromine in patients with major depressive disorder.
    Laux G; Classen W; Sofic E; Becker T; Riederer P; Lesch KP; Struck M; Beckmann H
    J Neural Transm Suppl; 1990; 32():189-95. PubMed ID: 2089089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
    Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
    Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial monoamine oxidase-A inhibition by moclobemide does not predict the therapeutic response in patients with major depression. A double blind, randomized study.
    Radat F; Berlin I; Spreux-Varoquaux O; Elatki S; Ferreri M; Puech AJ
    Psychopharmacology (Berl); 1996 Oct; 127(4):370-6. PubMed ID: 8923574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moclobemide (Aurorix) in primary major depression.
    Rihmer Z; Barsi J; Vad G; György S; Zalay B; Vég K; Gábor A
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):367-72. PubMed ID: 8208985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R; Márquez CA; Traballi CA; Portes N
    Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.